Clinical Trial Tests Cholesterol Drug to Minimize Multiple Sclerosis
Yale School of Medicine is participating in the first clinical trial testing atorvastatin to delay or decrease disease in patients who have experienced a first attack of multiple sclerosis (MS).
1 min read
